Press "Enter" to skip to content

BiomX Licenses Novel Targets for Liver Disease Phage Therapy Program From JSR Corporation in Japan – BioSpace

admin 0

BiomX Licenses Novel Targets for Liver Disease Phage Therapy Program From JSR Corporation in Japan  BioSpace

Published: Jun 11, 2019. Bacterial targets licensed were discovered by Professor Takanori Kanai of Keio University School of Medicine; Targets potentially affect …

“liver cancer” – Google News

(Visited 3 times, 1 visits today)

Leave a Reply

Your e-mail address will not be published. Required fields are marked *